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Abstract
Background: Past studies have shown that women with abnormal cytology or epithelial cells in
nipple aspirate fluid (NAF) have an increased relative risk (RR) of breast cancer when compared to
women from whom NAF was attempted but not obtained (non-yielders). This study analyzed NAF
results from a group of women seen in a breast clinic between 1970–1991 (N = 2480). Our analysis
presented here is an aggregate of two sub-groups: women with questionnaire data (n = 712) and
those with NAF visits beginning in 1988 (n = 238), the year in which cancer case information was
uniformly collected in California.
Methods: Cytological classification was determined for a group of 946 women using the most
abnormal epithelial cytology observed in fluid specimens. Breast cancer incidence and mortality
status was determined through June 2006 using data from the California Cancer Registry, California
Vital Statistics and self-report. We estimated odd ratios (ORs) for breast cancer using logistic
regression analysis, adjusting for age. We analyzed breast cancer risk related to abnormality of NAF
cytology using non-yielders as the referent group and breast cancer risk related to the presence or
absence of epithelial cells in NAF, using non-yielders/fluid without epithelial cells as the referent
group.
Results: Overall, 10% (93) of the 946 women developed breast cancer during the follow-up
period. Age-adjusted ORs and 95% confidence intervals (C.I.) compared to non-yielders were 1.4
(0.3 to 6.4), 1.7 (0.9 to 3.5), and 2.0 (1.1 to 3.6) for women with fluid without epithelial cells, normal
epithelial cells and hyperplasia/atypia, respectively. Comparing the presence or absence of epithelial
cells in NAF, women with epithelial cells present in NAF were more likely to develop breast cancer
than non-yielders or women with fluid without epithelial cells (RR = 1.9, 1.2 to 3.1).
Conclusion: These results support previous findings that 1) women with abnormal epithelial cells
in NAF have an increased risk of breast cancer when compared to non-yielders or women with
normal epithelial cells in NAF and 2) women with epithelial cells present in NAF have an increased
risk of breast cancer when compared to non-yielders or women who had NAF without epithelial
cells present.
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Background
Breast cancer is the second leading cause of cancer death
in women in the United States [1]. Of the 180,000 women
who will be diagnosed with breast cancer this year,
approximately 40,000 will die of this disease. Determin-
ing who is at risk for breast cancer has proven to be an
inexact science. Risk biomarkers with a lifetime positive
predictive value for breast cancer of >30% are limited to
individuals with a deleterious mutation in genes respon-
sible for hereditary breast cancer or a diagnosis of lobular
carcinoma in situ (LCIS) or atypical hyperplasia plus fam-
ily history of breast cancer in a woman undergoing a diag-
nostic biopsy. The vast majority of women interested in
risk assessment would not qualify for germline genetic
testing nor have they undergone a diagnostic biopsy [2].
Since 95% of breast tumors arise in the lining of the milk
ducts, evaluation of these ducts might be a means of iden-
tifying abnormal cells that could progress to cancer. Past
studies have shown that women with abnormal cytology
in nipple aspirate fluid (NAF) have an increased relative
risk (RR) of breast cancer when compared to women with
normal cytology in NAF and non-yielders (women from
whom NAF was attempted but not obtained) [3,4]. In
addition, a recent study found that women with epithelial
cells present in NAF, regardless of cytological category,
were more likely to develop breast cancer than women
with NAF that did not contain epithelial cells or non-
yielders [5].
This present study analyzed NAF results from a group of
women seen by Dr. Otto Sartorius in his Santa Barbara
breast clinic between 1970–1991. The purpose of this
paper is to present the results of a historic prospective
study determining 1) whether or not the type of epithelial
cells present in NAF (normal, hyperplasia or atypia) influ-
enced subsequent breast cancer development and 2)
whether or not there was an increased risk of breast cancer
development if epithelial cells were present in NAF,
regardless of cytological category.
Methods
Study population
Subjects were a cohort of 3,203 women seen by Dr. Otto
Sartorius in his Santa Barbara breast clinic between
1970–1991. The women were self-referred or referred by
physicians. Dr. Sartorius performed all NAF collection
during this period of time and utilized one pathologist to
determine cytological diagnoses for all specimens. NAF
collection/classification information and covariate infor-
mation (specifically age) used in this analysis was
abstracted from the subjects medical records by a team of
registered nurses in Santa Barbara, California. Age was the
only covariate information that could be consistently
abstracted from the medical records. The Committee on
Human Research of the University of California, San Fran-
cisco, and the Department of Defense (DOD) Human
Subjects Research Review Board approved this study of
human subjects.
Inclusion/exclusion criteria
All women seen by Dr. Sartorius between 1970–1991
were eligible for inclusion in the study (N = 3,203).
Women who were diagnosed with breast cancer at initial
visit with Dr. Sartorius or within six months of initial visit
with Dr. Sartorius were excluded from the study. Women
were also excluded who did not have NAF collection
attempted by Dr. Sartorius.
Follow-up protocol
Beginning in October 2005, all women were mailed struc-
tured questionnaires and consent forms requesting infor-
mation on personal and family history of breast cancer
and reproductive factors associated with an increased
breast cancer risk. After two mailings and no response we
attempted to contact the women by telephone. Several
methods were used to update the addresses of the non-
responders, including requests to the California Depart-
ment of Motor Vehicles (DMV), California Vital Statistics,
and several internet search engines. A modified proxy
questionnaire was sent to next-of-kin for subjects identi-
fied as deceased. Another source of information about
breast cancer status was the California Cancer Registry
(CCR), which did not uniformly begin collecting data on
breast cancer cases in California until 1988. Follow-up
ended in June, 2006.
The final model (N = 946) is composed of women who
were seen by Dr. Sartorius between 1970–1991 (Table 1).
Breast cancer status upon follow-up was determined
either by a returned questionnaire or by linkage with the
CCR. A comparison of the group of women included in
the final analysis versus the women excluded from the
final analysis is shown in Table 2.
Nipple aspiration technique and cytologic classification
Nipple aspirate was obtained using the technique devel-
oped by Dr. Sartorius and has been described elsewhere
[6,7]. The clinical database used for this study contained a
variety of cytologic classifications. These classifications
were condensed and categorized as either 1) normal cells
2) hyperplasia or 3) atypical hyperplasia by our study
pathologist, Dr. Eileen King. [8]. For this analysis, the
most abnormal epithelial changes observed in the fluid
specimens were used for the date of age at study entry.
Data analysis
This paper evaluates breast cancer risk in relation to NAF
cytology results which were categorized as follows: no
fluid obtained, fluid without epithelial cells, normal/BMC Cancer 2008, 8:75 http://www.biomedcentral.com/1471-2407/8/75
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benign, hyperplasia, atypia, and unable to classify. For
women with multiple NAF results, the most abnormal
result was used. While data on timing of cancer and death
was available, precise dates on censoring of unaffected
and living people was not and thus logistic regression was
determined to be the appropriate analytic method for use
in this study.
Two logistic regression models were used in the analyses
presented here. The first model used the non-yielders
group of women as the referent and calculated the odds
ratio for women who had fluid without epithelial cells,
normal, or hyperplasia/atypia combined. The decision to
use the non-yielders as the referent is consistent with past
studies and the hypothesis that women without NAF
Table 1: Population of eligible women used in final analysis, Sartorius Cohort 1970–1991.
3203 Total number in tracking database
(- 159) No cytology results at all
(- 200) Results from histology only, no NAF attempted
(- 364) With breast cancer within 6-months of most severe NAF result
TOTAL # ELIGIBLE 2480 With NAF results and no breast cancer within 6-months of severe NAF result visit 
(note: this includes 9 women with breast cancer dates unknown)
Subset of women used in this analysis:
712 Women with questionnaire data
238 Women seen 1/01/1988 or after
950
(- 3) "Unable to classify" NAF result
(- 1) Age missing (NAF date missing)
Total number in model 946
Total number not in model 1534
Table 2: Comparison between women excluded from the final analysis versus those included in the final analysis, Sartorius Cohort 
1970–1991.
Excluded from Analysis Included in Analysis
Basic Stats N = 1534 N = 946 ANOVA
Age at NAF visit:
Mean 43.9 * 42.6
Median 42 41
Std Err 0.39 0.42
Min-max 16–89 16–87
p = 0.04
Age at breast cancer diagnosis:
N 81 ** 93
Mean 62.0 60.8
Median 62 62
Std Err 1.5 1.27
Min-max 30–89 34–86
p = 0.54
Breast cancer: n (%) n (%)
90 (6%) 93 (10%) Chi Square
p <0.001
NAF Cytology: n (%) n (%)
No fluid 929 (61%) 714 (75%)
Insufficient specimen 45 (3%) 19 (2%)
Normal 232 (15%) 89 (9%)
Hyperplasia 234 (15%) 97 (10%)
Atypia 81 (5%) 27 (3%)
[Unable to classify] 13 (1%)
p <0.001
* N = 1525
** 9 missing NAF ageBMC Cancer 2008, 8:75 http://www.biomedcentral.com/1471-2407/8/75
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secretions are at a lower risk of developing breast cancer
than women who produce breast fluids [3]. The second
model tested the hypothesis that the presence of epithelial
cells may be a risk factor for breast cancer. In this case the
non-yielders and fluid without epithelial cells groups
were combined as the referent. All other women com-
prised the non-referent group (normal, hyperplasia, aty-
pia, and unable to classify). Both models adjusted for age
at the time of the NAF visit.
The PROC LOGISTIC procedure in SAS version 9.1 [9]
was used to generate the odds ratios for these analyses.
Results
Description of the cohort and follow-up
Of the 946 women in the final model, data on breast can-
cer status was obtained on 712 (75%) by completed ques-
tionnaire data and on 238 (25%) from linkage with the
CCR database. The women with completed follow-up
were between ages 16–87 at study entry, with a mean age
of 42.6. Mean follow-up time was 20.7 years, the median
was 20 years and the range was 0.10 to 35 years. The mean
age at breast cancer diagnosis was 60.8 years with a range
of 34–86. Seventy-five percent (714) of the cohort were
non-yielders versus 24% (232) of women who produced
fluid either with or without epithelial cells. As of June
2006, 93 of 946 (10%) women had developed breast can-
cer since enrollment in the study (Table 2). Of the breast
cancer cases reported, 75 were self-reported and the
remaining 18 were determined solely via the CCR.
Breast cancer incidence by cytologic diagnosis
In our review of the type of epithelial cells present in NAF
and subsequent breast cancer development, a progressive
increase in breast cancer cases was seen with each progres-
sive category of cytology (Table 3). Breast cancer incidence
was 9% (63 of 714) in the non-yielders group, 11% (2 of
19) in women who had fluid without epithelial cells, 12%
(11 of 89) in women with normal epithelial cells, and
14% (17 of 124) in women with hyperplasia/atypia.
Women who had fluid without epithelial cells were 1.4
times more likely to develop breast cancer than non-yield-
ers (95% CI, 0.3–6.4). Women with normal epithelial
cells in NAF were 1.7 times more likely to develop breast
cancer than non-yielders (95% CI, 0.9–3.5). Women with
proliferative epithelial cells in NAF (hyperplasia/atypia)
were 2 times more likely to develop breast cancer than
non-yielders (95% CI, 1.1–3.6, p value = 0.02).
Breast cancer incidence by presence or absence of 
epithelial cells
An increased risk of breast cancer was also found in our
comparison of solely the presence of epithelial cells in
NAF, regardless of cytological category (Table 3). Women
with any epithelial cells in NAF were 1.9 times more likely
to develop breast cancer than non-yielders or women who
had fluid from NAF that did not contain epithelial cells
(95% CI, 1.2–3.1, p value = 0.01).
Discussion
Interrogating the breast epithelium directly with core nee-
dle biopsy is an unrealistic tool for determination of risk
for the majority of women without significant family his-
tory or other major risk factors for breast cancer. Nipple
aspiration is an inexpensive, non-invasive method for
evaluating breast epithelium. Tice et al. [10] found that
NAF cytology may improve the Gail model's predictive
ability, especially for women with high risk. Information
regarding proliferative breast epithelium is currently
obtained for use in the Gail model via biopsy, an invasive
and unrealistic screening tool for large populations of
women. Breast biopsies are performed once a woman is
symptomatic, limiting their ability to provide predictive
value in determining who is at risk for breast cancer. The
use of NAF is a relatively inexpensive, non-invasive route
for evaluating breast epithelium, the site of 90% of diag-
nosed breast cancer cases.
This study used the results from the NAF sample with the
most abnormal results in the final analysis. In order to
address the issue of possible bias introduced by using
these subsequent samplings for some women, we re-ran
our analysis using the data from the first sampling for all
subjects. Our results were almost identical; all ORs and
Table 3: Odds ratios of breast cancer risk by cytological categories and presence of epithelial cells in NAF, Sartorius Cohort 
1970–1991.
Breast cancer by cytology: In model: N = 946 # with breast cancer n % OR 95% CI p-value
No fluid 63 714 9% 1.0 (referent)
Fluid without epithelial cells 2 19 11% 1.4 0.32–6.4 0.64
Normal 11 89 12% 1.7 0.87–3.5 0.12
Hyperplasia or atypia 17 124 14% 2.0 1.1–3.6 0.02
Any epithelial cells:
No fluid/insufficient specimen 65 733 9% 1.0 (referent)
Unable to classify, normal, hyperplasia, atypia 28 213 13% 1.9 1.2–3.1 0.01BMC Cancer 2008, 8:75 http://www.biomedcentral.com/1471-2407/8/75
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statistics remained the same. In addition, we re-analyzed
the data on subjects stratified according to three age
groups; less than 45 years, 45–54 years and 55 years or
older. Our population in the less than 45 year old group
was too small to analyze (N-48) and in the 45–54 year old
age group, the number with breast cancer was only 6.
Despite these small numbers, the trend was nearly identi-
cal to the original analysis combining all groups.
Our findings are consistent with the findings of other
recent studies and appear to confirm that women with cel-
lular NAF have a higher risk of cancer than those with no
NAF or NAF without epithelial cells [3-5]. Wrensch et al.
[4] found a 2–5 fold greater risk of breast cancer develop-
ment in women with proliferative epithelial cells in NAF
when compared to women with normal epithelial cells in
NAF and non-yielders. Buehring et al. [5] found women
with any epithelial cells in NAF had a 2-fold greater risk of
breast cancer development when compared to non-yield-
ers or women with NAF fluid that did not contain epithe-
lial cells. These findings confirm that women with
epithelial cells in NAF, normal or abnormal, are at a
greater risk of developing breast cancer. Past studies have
shown that younger women are more likely to yield NAF
fluid for evaluation [7,11]. These women are less likely to
benefit from current breast cancer screening modalities,
making NAF an important adjunct to presently employed
screening modalities.
There were limitations involved in the conducting of this
study. First, due to the inability to accurately track breast
cancer cases prior to 1988, we were unable to use informa-
tion from the cohort without questionnaire data prior to
1988. In addition, the women in the study were visiting a
breast clinic and the majority presented with breast symp-
toms for evaluation. Although no formal evaluation of
breast cancer risk (i.e. the Gail model) was utilized by Dr.
Sartorius, this cohort is likely to represent a high risk
group and the results cannot be generalized to the popu-
lation at large. Finally, the ethnic make-up of this cohort
was predominantly white; therefore the relative risks
found may not be applicable to other ethnicities with var-
ying physiologic factors influencing breast epithelium.
Conclusion
These results support our hypothesis that 1) women with
abnormal epithelial cells in NAF have an increased risk of
breast cancer when compared to non-yielders and women
with normal epithelial cells in NAF and 2) women with
epithelial cells present in NAF have an increased risk of
breast cancer when compared to non-yielders and women
without epithelial cells present in NAF. As early detection
of breast cancer is critical for a cure, being able to identify
women at high risk for breast cancer would justify closer
follow-up and the use of multiple methods to ensure early
detection. Examining NAF may enhance current risk pre-
diction models and provide an easy and inexpensive way
to help identify individuals at increased risk for breast
cancer. Future studies are necessary to explain the associa-
tion between our findings and increased breast cancer
risk. It is necessary to test breast fluids for specific biomar-
kers in order to further the research on etiologic factors
involved in breast carcinogenesis and true breast cancer
prevention.
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